Corticosteroid injections have been shown to be an effective treatment modality in many of the musculoskeletal and rheumatologic conditions. Yet, the potential adverse effects of corticosteroid injections have not been given much attention. One of the potential adverse effects that should be considered by clinicians is skin hypopigmentation and subcutaneous fat atrophy. Although it is a rare side effect, it may have cosmetically unpleasant effect. The aim of this case report is to highlight the importance of providing adequate information to the patients regarding these dermal adverse effects of corticosteroid injections. We report the case of a 31-year-old female who suffered from skin hypopigmentation and subcutaneous fat atrophy after triamcinolone injection given for de Quervain's tenosynovitis.

Original languageEnglish
Pages (from-to)807-811
Number of pages5
JournalAnaesthesia, Pain and Intensive Care
Issue number6
Publication statusPublished - 1 Dec 2021


  • Adverse effects
  • Corticosteroid injections
  • De Quervain's tenosynovitis
  • Fat atrophy
  • Hypopigmentation
  • Pain


Dive into the research topics of 'Hypopigmentation and subcutaneous fat atrophy associated with corticosteroid injection: A case report'. Together they form a unique fingerprint.

Cite this